Cadrenal Therapeutics (CVKD) Stock: Buy, Sell, or Hold?
CVKD - Cadrenal Therapeutics, Inc. Common Stock
$1.12
-0.03 (-2.61%)
âŧ
5d:
+2.75%
30d:
-28.43%
90d:
-62.91%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When CVKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CVKD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CVKD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CVKD is currently trading at $1.12, which is considered slightly low relative to its 30-day fair value range of $1.08 to $1.50.
Technical Outlook: Technically, CVKD is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.35.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.00 (+1150.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVKD is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.35.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.00 (+1150.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.08 -
$1.50
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 1150.0% below Wall St target ($14.00)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.08 -
$1.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.01
Resistance Level
$1.36
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.33
Wall Street Target
$14.00
(+1150.0%)
Share & Embed Analysis
Last updated: September 29, 2026 9:19 AM ET
Data refreshes hourly during market hours. Next update: 10:19 AM
Data refreshes hourly during market hours. Next update: 10:19 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$371 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$570 | 52 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 59 HOLD |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
13 analysts |
$52 | 66 BUY |
